Solid Biosciences' Series C Round

Solid Biosciences raised a round of funding on March 30, 2017.

Solid Biosciences is a gene therapy platform focused on developing novel, disease-modifying therapeutics for Duchenne muscular dystrophy. The company's licensed technology has demonstrated efficacy in…

Articles about Solid Biosciences' Series C Round: